SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001048477-21-000023
Filing Date
2021-07-28
Accepted
2021-07-28 16:10:03
Documents
14
Period of Report
2021-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20210728.htm   iXBRL 8-K 33049
2 EX-99.1 bmrn-21xjulyxex991.htm EX-99.1 385181
6 GRAPHIC bmrnlogoa01a.jpg GRAPHIC 3615
  Complete submission text file 0001048477-21-000023.txt   590890

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20210728.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20210728_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20210728_pre.xml EX-101.PRE 12601
7 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20210728_htm.xml XML 10766
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 211122636
SIC: 2834 Pharmaceutical Preparations